MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/keab532

Медицинская библиотека · Rheumatology (Oxford, England) · 2022

Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.

Ottria Andrea, Zimmermann Maili, Paardekooper Laurent M, Carvalheiro Tiago, Vazirpanah Nadia, Silva-Cardoso Sandra, Affandi Alsya J, Chouri Eleni, V D Kroef Maarten, Tieland Ralph G, Bekker Cornelis P J, Wichers Catharina G K, Rossato Marzia, Mocholi-Gimeno Enric, Tekstra Janneke, Ton Evelien, van Laar Jaap M, Cossu Marta, Beretta Lorenzo, Garcia Perez Samuel, Pandit Aridaman, Bonte-Mineur Femke, Reedquist Kris A, van den Bogaart Geert, Radstake Timothy R D J, Marut Wioleta

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

SSc is a complex disease characterized by vascular abnormalities and inflammation culminating in hypoxia and excessive fibrosis. Previously, we identified chemokine (C-X-C motif) ligand 4 (CXCL4) as a novel predictive biomarker in SSc. Although CXCL4 is well-studied, the mechanisms driving its production are unclear. The aim of this study was to elucidate the mechanisms leading to CXCL4 production.

METHODS

Plasmacytoid dendritic cells (pDCs) from 97 healthy controls and 70 SSc patients were cultured in the presence of hypoxia or atmospheric oxygen level and/or stimulated with several toll-like receptor (TLR) agonists. Further, pro-inflammatory cytokine production, CXCL4, hypoxia-inducible factor (HIF) -1α and HIF-2α gene and protein expression were assessed using ELISA, Luminex, qPCR, FACS and western blot assays.

RESULTS

CXCL4 release was potentiated only when pDCs were simultaneously exposed to hypoxia and TLR9 agonist (P < 0.0001). Here, we demonstrated that CXCL4 production is dependent on the overproduction of mitochondrial reactive oxygen species (mtROS) (P = 0.0079) leading to stabilization of HIF-2α (P = 0.029). In addition, we show that hypoxia is fundamental for CXCL4 production by umbilical cord CD34 derived pDCs.

CONCLUSION

TLR-mediated activation of immune cells in the presence of hypoxia underpins the pathogenic production of CXCL4 in SSc. Blocking either mtROS or HIF-2α pathways may therapeutically attenuate the contribution of CXCL4 to SSc and other inflammatory diseases driven by CXCL4.

Для цитирования: Ottria Andrea, Zimmermann Maili, Paardekooper Laurent M, Carvalheiro Tiago, Vazirpanah Nadia, Silva-Cardoso Sandra, Affandi Alsya J, Chouri Eleni, V D Kroef Maarten, Tieland Ralph G, Bekker Cornelis P J, Wichers Catharina G K, Rossato Marzia, Mocholi-Gimeno Enric, Tekstra Janneke, Ton Evelien, van Laar Jaap M, Cossu Marta, Beretta Lorenzo, Garcia Perez Samuel, Pandit Aridaman, Bonte-Mineur Femke, Reedquist Kris A, van den Bogaart Geert, Radstake Timothy R D J, Marut Wioleta. Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.. Rheumatology (Oxford, England). 2022. DOI: 10.1093/rheumatology/keab532.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.